1-(2,4-Xylyl)piperazine → HCID 71251911, compound
Reaction equation
[N:1]1([C:10]2[CH:19]=[CH:18][C:13]([C:14]([O:16]C)=O)=[CH:12][CH:11]=2)[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[CH:2]1.[CH3:20][C:21]1[CH:26]=[C:25]([CH3:27])[CH:24]=[CH:23][C:22]=1[N:28]1[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]1>>[N:1]1([C:10]2[CH:11]=[CH:12][C:13]([C:14]([N:31]3[CH2:32][CH2:33][N:28]([C:22]4[CH:23]=[CH:24][C:25]([CH3:27])=[CH:26][C:21]=4[CH3:20])[CH2:29][CH2:30]3)=[O:16])=[CH:18][CH:19]=2)[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[CH:2]1Participants
3
Procedure
Using methyl 4-(benzimidazol-1-yl)benzoate (126 mg) and 1-(2,4-dimethylphenyl)piperazine (95 mg) and by the reaction and treatment in the same manner as in Example 109, the title compound (114 mg) was obtained.
Workup
- customby the reaction and treatment in the same manner as in Example 109
Sources & evidence
- ORD record
- ord-9a6350d9ad7a438cab56df856760c36c
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…